The new 36-person group strengthens capabilities at the law firm that Charlotte-based leadership says have long been adjacent to its core work.
Durham's BioCryst has acquired a Boston drugmaker with a new treatment that executives say has strong potential.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results